SCHEMBL25323332

SCHEMBL25323332

c1ccc(Nc2ccc(N(c3ccc(N(c4ccccc4)c4cccc5ccccc45)cc3)c3ccc(N(c4ccccc4)c4cccc5ccccc45)cc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
HSD17B10 Q99714 4/20 0.47
HPGD P15428 4/20 0.47
CYP3A4 P08684 3/20 0.47
ALOX15 P16050 2/20 0.47
TSHR P16473 2/20 0.47
CDC25B P30305 2/20 0.47
TP53 P04637 1/20 0.47
ATM Q13315 1/20 0.47
SIGMAR1 Q99720 3/20 0.44
TDP1 Q9NUW8 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
ALOX12 P18054 1/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42
MAPK1 P28482 1/20 0.42
PTGS2 P35354 1/20 0.42
HTR2B P41595 1/20 0.42
KDM1A O60341 3/20 0.39
MAPT P10636 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13190705 1.00 ALDH1A1 (0.47) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL12700539 0.98 ALDH1A1 (0.44) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL1034193 0.98 ALDH1A1 (0.49) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL6817030 0.97 HSD17B10 (0.46) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL18055092 0.97 HSD17B10 (0.46) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL13780630 0.95 ALDH1A1 (0.44) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL12700559 0.95 ALDH1A1 (0.44) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL1507961 0.94 ALDH1A1 (0.45) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL29507343 0.94 ALDH1A1 (0.45) ALDH1A1HSD17B10HPGDCYP3A4ALOX15
SCHEMBL23709146 0.94 ALDH1A1 (0.45) ALDH1A1HSD17B10HPGDCYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247899-A1 ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR DUK SAN NEOLUX CO., LTD. (KR) 2023-08-03 US disclosed
US-20230125420-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247899-A1 ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR SLC39A11, LEF1, SLC39A14 ALDH1A1 670/4885HSD17B10 1957/4885HPGD 2658/4885
US-20230125420-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF OR51E2, NFE2L2, ETV6 ALDH1A1 1417/4885HSD17B10 3279/4885HPGD 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.